Renaissance Technologies’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,336
| Closed | -$71.6K | – | 3634 |
|
|
2024
Q2 | $71.6K | Buy |
5,336
+52
| +1% | +$698 | ﹤0.01% | 3241 |
|
|
2024
Q1 | $92K | Buy |
5,284
+92
| +2% | +$1.6K | ﹤0.01% | 3384 |
|
|
2023
Q4 | $107K | Buy |
5,192
+116
| +2% | +$2.39K | ﹤0.01% | 3290 |
|
|
2023
Q3 | $84K | Sell |
5,076
-3,116
| -38% | -$51.6K | ﹤0.01% | 3283 |
|
|
2023
Q2 | $213K | Sell |
8,192
-348
| -4% | -$9.05K | ﹤0.01% | 3276 |
|
|
2023
Q1 | $216K | Sell |
8,540
-2,560
| -23% | -$64.7K | ﹤0.01% | 3246 |
|
|
2022
Q4 | $278K | Sell |
11,100
-6,665
| -38% | -$167K | ﹤0.01% | 3258 |
|
|
2022
Q3 | $475K | Buy |
17,765
+9,097
| +105% | +$243K | ﹤0.01% | 2951 |
|
|
2022
Q2 | $282K | Buy |
8,668
+1,092
| +14% | +$35.5K | ﹤0.01% | 3486 |
|
|
2022
Q1 | $277K | Buy |
+7,576
| New | +$277K | ﹤0.01% | 3504 |
|
|
2021
Q2 | – | Sell |
-1,577
| Closed | -$1.35M | – | 3553 |
|
|
2021
Q1 | $1.35M | Buy |
1,577
+896
| +132% | +$768K | ﹤0.01% | 2461 |
|
|
2020
Q4 | $620K | Buy |
681
+188
| +38% | +$171K | ﹤0.01% | 2726 |
|
|
2020
Q3 | $598K | Buy |
+493
| New | +$598K | ﹤0.01% | 2754 |
|
|
2020
Q1 | – | Sell |
-121
| Closed | -$24K | – | 3540 |
|
|
2019
Q4 | $24K | Sell |
121
-909
| -88% | -$180K | ﹤0.01% | 3441 |
|
|
2019
Q3 | $256K | Buy |
1,030
+952
| +1,221% | +$237K | ﹤0.01% | 3079 |
|
|
2019
Q2 | $196K | Buy |
78
+4
| +5% | +$10.1K | ﹤0.01% | 3304 |
|
|
2019
Q1 | $302K | Buy |
+74
| New | +$302K | ﹤0.01% | 3093 |
|